Clinical Trial Update: Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating MMX mesalamine once daily for maintaining or achieving clinical and endoscopic remission in adults with ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• MMX Mesalamine (mesalamine)

Snippet

Sponsor: Shire | Conditions: Ulcerative Colitis | Phase 4 | Status: COMPLETED | Results posted: 2013-12-02